CYMABAY THERAPEUTICS, INC.
7575 Gateway Blvd., Suite 110
Newark, CA 94560
(510) 293-8800
February 7, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Todd Schiffman
RE: | CymaBay Therapeutics, Inc. |
Registration Statement on Form S-3
File No. 333-229082
Ladies and Gentlemen:
CymaBay Therapeutics, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on February 11, 2019, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Very truly yours, | ||
CymaBay Therapeutics, Inc. | ||
By: | /s/ Sujal Shah | |
Sujal Shah | ||
President and Chief Executive Officer |